Quinolone analogs as cell proliferation inhibitors

Details for Australian Patent Application No. 2005286965 (hide)

Owner Cylene Pharmaceuticals, Inc.

Inventors Nagasawa, Johnny Y.; Jung, Michael; Yiannikouros, George Petros; Regan, Collin; Pierre, Fabrice; Schwaebe, Michael; Whitten, Jeffrey P.; Chua, Peter

Agent Pizzeys

Pub. Number AU-B-2005286965

PCT Pub. Number WO2006/034113

Priority 60/611,030 17.09.04 US; 11/149,007 09.06.05 US; 60/638,603 22.12.04 US; 60/688,986 09.06.05 US; 60/688,796 09.06.05 US

Filing date 16 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 22 October 2009

International Classifications

A61K 31/4743 (2006.01)

A61K 31/4745 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 513/14 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/034113 Priority application(s): WO2006/034113

22 October 2009 Application Accepted

  Published as AU-B-2005286965

18 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286968-Diaminotriazole compounds useful as protein kinase inhibitors

2005286955-Reactor and process for steam reforming